Recently, Congressman Kevin Cramer joined a bi-partisan majority of the U.S. House of Representatives Energy and Commerce Committee to pass 21st Century Cures by a vote of 51 -- 0. This committee vote is another step in a 2-year process to reform our health care regulatory process and allow innovation to fight and to cure diseases in our country. America has been a leader in medical innovation and breakthroughs, but despite our continued successes government rules and regulations threaten our leadership in health care innovation.
"Our goal must be to create a regulatory environment where American innovators are not at a competitive disadvantage to foreign companies. Liberating our medical innovators from needless bureaucracy and regulation will ensure Americans are the ultimate winners with improved access to new medicines and medical treatments while protecting US medical and biomedical jobs. This legislation brings hope and medical cures to many patients and their families who have run out of options," said Cramer.